Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

ARCHIMED acquires Spanish radiopharmaceutical specialist IRAB

Healthcare-focused private equity firm ARCHIMED has acquired Barcelona-based Institut de Radiofarmàcia Aplicada de Barcelona (IRAB), a developer, manufacturer and supplier of PET radiopharmaceuticals used in medical imaging, clinical trials and biomedical research.
June 11, 2026

Huron acquires RelateCare from MML Ireland

Huron, a Nasdaq-listed global professional services firm, has acquired AI-enabled clinical and patient access solutions provider RelateCare from private equity firm MML Growth Capital Partners Ireland.
June 11, 2026

Terveystalo buys Finnish ophthalmology provider Silmäasema

Terveystalo, Finland’s second-largest private hospital group, is buying Silmäasema, a Finnish eye-care and optical retail company, for ~€574 million (partial share-swap deal). The seller is private equity firm CapMan Growth. €275 million of this will be paid in cash, and the rest will be funded through 36.5 million new Terveystalo shares.
June 11, 2026

Bridgepoint to acquire Obagi Medical from Waldencast

Mid-market private equity firm Bridgepoint Group has agreed to acquire US-based Obagi Medical, a dermatological skincare and aesthetics business, from Nasdaq-listed beauty and wellness group Waldencast, for an enterprise value of up to $460 million (~€399.00 million).
June 11, 2026

Cooper Consumer Health acquires Ferrer’s consumer health business

European consumer healthcare group Cooper Consumer Health has acquired the consumer health business of Spanish pharmaceutical company Ferrer. The deal strengthens Cooper’s presence in Spain, where it already works with more than 20,000 pharmacies, and expands its portfolio in a core European market that has become increasingly important to its growth strategy.
June 11, 2026

HBI webinar on Value Creation in Healthcare Organisations

HBI hosted a webinar this week on the topic of value creation in healthcare organisations. The discussion looked at how healthcare providers are using digital tools, operational improvements and AI to build more connected and scalable organisations. Missed the webinar? Watch the recoding here.
June 11, 2026

Interview with Niklas Kouparanis, founder and CEO of Europe’s largest medical cannabis digital health company, Bloomwell

Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).
June 4, 2026

France’s obesity drug reimbursement plan could reshape insurers’ role in care

France will begin reimbursing anti-obesity medicines from mid-June 2026, becoming the first EU country to introduce public coverage for treatments including Wegovy and Mounjaro, produced by Danish pharma giant Novo Nordisk and American pharmaceutical company Eli Lilly respectively. The policy is intended to prioritise high-risk patients rather than general weight management. Access will be limited to patients with severe obesity, defined as a BMI of at least 40, or at least 35 where accompanied by conditions such as type 2 diabetes or cardiovascular disease.
June 4, 2026
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us